“…we’ve seen local [Minneapolis-St. Paul] trends in startup life cycles that may play a role in making innovation and acquisitions possible. The medtech field, defined as products that require regulatory approval, is one of them. Medtech saw $230 million in venture capital funding deals in Minnesota last year. In December, the Greater MSP Partnership announced that it will be awarded up to $500,000 to promote eight planned “bio-innovation” projects related to human health, food and agriculture across the metro area, the starting point for its proposed new Bold North BioInnovation Cluster.” Excerpt from Minneapolis/St. Paul Business Journal. Read the full article.
Along with many other distinguished organizations, UEL has taken an active role in planning and securing funding through the U.S. Build Back Better program for Bold North BioInnovation Cluster .
Learn more about the vision, scope and community contributions stemming from the Bold North BioInnovation Cluster initiative.